keyboard_arrow_up

Global Irritable Bowel Syndrome Market to Grow at 14.04% CAGR by 2019

Global Irritable Bowel Syndrome Market 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection.

This report covers the present scenario and the growth prospects of the Global Irritable Bowel Syndrome market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of irritable bowel syndrome.

Analysts forecast the Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019.

Single User License of the report is Available at US $2500

Global Irritable Bowel Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Irritable Bowel Syndrome market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The report recognizes the following companies as the key players in the Global Irritable Bowel Syndrome Market: Actavis plc, Astellas Pharma Inc., Nestlé SA and Takeda Pharmaceutical Co. Ltd.

Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=27593 .

Other Prominent Vendors in the market are: Abbott, Alba Therapeutics, Alfa Wassermann, Alizyme, Almirall, AltheRx Pharmaceuticals, Ardelyx, AstraZeneca, Bayer, Bristol-Myers Squibb, Sumitomo Dainippon Pharma, Dong-A Socio Holdings, Drais Pharmaceuticals, Dynogen, gIcare Pharma, GlaxoSmithKline, Hanmi Pharmaceuticals, ImmusanT, Ironwood Pharmaceuticals, Janssen, Lexicon Pharmaceuticals, Menarini, MicroDose Therapeutx, Norgine, Novartis, Ocera Therapeutics, Ono Pharmaceutical, Par Pharmaceutical, Pfizer, Pharmos, Protagonist Therapeutics, RaQualia Pharma, Rottapharm, Salix, Seldar Pharma, Shire, SK Chemicals, SOFAR, Synergy Pharmaceuticals, Synthetic Biologics, Tioga Pharmaceuticals, Tsumura and Yuhan.

One major trend upcoming in this market is an increase in public awareness about irritable bowel syndrome, which is expected to increase the number of treatment-seeking patients, thereby increasing the consumption of medications. Growing public awareness increases the number of treatment-seeking patients, thereby leading to increased consumption of approved medications.

According to the report, the presence of huge unmet needs in the field of irritable bowel syndrome is one of the major drivers of the market. There is a lack of a significant number of drugs approved by the FDA, and the use of generics and off-label drugs causes erosion in the market share of labeled products. This provides vendors with an opportunity to produce new drugs, which can give them an edge over others and hence, grab a major portion of the market.

Further, the report states that the high cost of drugs to treat irritable bowel syndrome is a major challenge to the growth of the market. It causes non-compliance in patients, leading to an increase in the churn-out rate of patients from the treatment. This results in restrained growth of the market.

Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Market Landscape
08. Market Segmentation by Mechanism of Action
09. Market Segmentation by Dosage Form
10. Market Segmentation by Indication
11. Market Segmentation by End User Gender
12. Geographical Segmentation
13. Rate of Incidence and Prevalence
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
22. Pipeline Portfolio
23. Key Vendor Analysis
24. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Irritable Bowel Syndrome Market 2014-2019 (US$ million)
Exhibit 3: Global Irritable Bowel Syndrome Market Segmentation by Mechanism of Action
Exhibit 4: Global Irritable Bowel Syndrome Market Segmentation by Mechanism of Action 2014
Exhibit 5: Global Irritable Bowel Syndrome Market Segmentation by Dosage Form
Exhibit 6: Global Irritable Bowel Syndrome Market Segmentation by Dosage Form 2014
Exhibit 7: Global Irritable Bowel Syndrome Market Segmentation by Indication
Exhibit 8: Global Irritable Bowel Syndrome Market Segmentation by Mechanism of Action 2014
Exhibit 9: Global Irritable Bowel Syndrome Market Segmentation by End User Gender
Exhibit 10: Global Irritable Bowel Syndrome Market Segmentation by End User Gender 2014
View all 30 Exhibits

Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=27593 .

About US:

Sandlerresearch.org (http://www.sandlerresearch.org) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.